Valeant Pharmaceuticals is planning sweeping changes to its board of directors as it moves to set a new tone at the top of a company under fire from politicians and investors for its management and drug-pricing practices.
WSJ.com: Health, Wall Street Journal: Business: Health
Wed, 04/27/2016 - 9:47pm
Valeant Pharmaceuticals is planning sweeping changes to its board of directors as it moves to set a new tone at the top of a company under fire from politicians and investors for its management and drug-pricing practices.